CytoMed Therapeutics Limited (GDTC)

NASDAQ: GDTC · IEX Real-Time Price · USD
2.170
-0.050 (-2.25%)
At close: Mar 28, 2024, 9:31 AM
2.080
-0.090 (-4.15%)
After-hours: Mar 28, 2024, 6:26 PM EDT

Total Valuation

GDTC has a market cap or net worth of $25.83 million. The enterprise value is $18.44 million.

Market Cap 25.83M
Enterprise Value 18.44M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

GDTC has 11.53 million shares outstanding. The number of shares has increased by 95.49% in one year.

Shares Outstanding 11.53M
Shares Change (YoY) +95.49%
Shares Change (QoQ) +45.66%
Owned by Insiders (%) 70.80%
Owned by Institutions (%) 0.08%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 45.02
Forward PS 48.69
PB Ratio 2.65
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 32.15
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 36.42, with a Debt / Equity ratio of 0.04.

Current Ratio 36.42
Quick Ratio 36.42
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -40.32

Financial Efficiency

Return on equity (ROE) is -58.30% and return on invested capital (ROIC) is -18.42%.

Return on Equity (ROE) -58.30%
Return on Assets (ROA) -45.00%
Return on Capital (ROIC) -18.42%
Revenue Per Employee $21,244
Profits Per Employee -$117,873
Employee Count 27
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, GDTC has paid $1,216 in taxes.

Income Tax 1,216
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average 2.64
200-Day Moving Average 3.46
Relative Strength Index (RSI) 43.78
Average Volume (30 Days) 38,395

Short Selling Information

The latest short interest is 19,259, so 0.17% of the outstanding shares have been sold short.

Short Interest 19,259
Short Previous Month 19,285
Short % of Shares Out 0.17%
Short % of Float n/a
Short Ratio (days to cover) 2.04

Income Statement

In the last 12 months, GDTC had revenue of $573,593 and -$3.18 million in losses. Loss per share was -$0.36.

Revenue 573,593
Gross Profit n/a
Operating Income -1.86M
Pretax Income -3.18M
Net Income -3.18M
EBITDA -2.80M
EBIT -3.10M
Loss Per Share -$0.36
Full Income Statement

Balance Sheet

The company has $7.74 million in cash and $349,946 in debt, giving a net cash position of $7.39 million or $0.64 per share.

Cash & Cash Equivalents 7.74M
Total Debt 349,946
Net Cash 7.39M
Net Cash Per Share $0.64
Equity / Book Value 9.76M
Book Value Per Share 0.85
Working Capital 8.27M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.21 million and capital expenditures -$50,667, giving a free cash flow of -$2.26 million.

Operating Cash Flow -2.21M
Capital Expenditures -50,667
Free Cash Flow -2.26M
FCF Per Share -$0.20
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -324.61%
Pretax Margin -554.64%
Profit Margin -554.85%
EBITDA Margin -488.88%
EBIT Margin -541.21%
FCF Margin -393.97%

Dividends & Yields

GDTC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -95.49%
Shareholder Yield -95.49%
Earnings Yield -12.32%
FCF Yield -8.75%

Analyst Forecast

The average price target for GDTC is $5.00, which is 130.42% higher than the current price. The consensus rating is "Buy".

Price Target $5.00
Price Target Difference 130.42%
Analyst Consensus Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GDTC has an Altman Z-Score of 27 and a Piotroski F-Score of 3.

Altman Z-Score 27
Piotroski F-Score 3